Martin Cevallos-Cueva, MD retweeted
What makes a meta-analysis believable?
In our latest issue, a new Viewpoint outlines how to identify meta-analyses that merit clinical confidence.
Explore the full issue: spkl.io/60197rxth
Martin Cevallos-Cueva, MD retweeted
The 2026 #Dyslipidemia guideline expands primary prevention #statin eligibility in the US to include more than half of adults aged 30-79 years, including patients with #chronic #kidney #disease and elevated lifetime #ASCVD risk.
ja.ma/3T6RJyE
Can patients with moderate-to-severe #plaquepsoriasis safely switch from #ustekinumab (UST) to its #biosimilars?
Our study in #jeadv found comparable PASI 75/90/100 and PGA 0/1 response rates, safety profiles and immunogenicity across UST biosimilars
doi.org/10.1111/jdv.70616 – at Rumiñahui, Ecuador
1
107
Grateful to have reached 100 citations.
A small but meaningful milestone in my academic journey, and a reminder of how much I still have to learn and contribute.
Thank you to my mentors and peers who have supported me along the way.
#DermatologyResearch
scholar.google.com/citations… – at Pichincha, Ecuador
1
85
#Icotrokinra, a first-in-class oral IL-23 antagonist, showed strong efficacy in patients with moderate-to-severe plaque #psoriasis across 5 #RCTs (n=2,755).
It significantly improved IGA 0/1 and PASI 75/90/100 responses with an acceptable safety profile.
doi.org/10.1007/s10787-026-0… – at Quito, Ecuador
1
132
Grateful for the opportunity to present our research at the @SocInvestDerm Annual Meeting 2026.
Every abstract, every presentation and every manuscript brings me one step closer to my dream becoming a dermatologist.
#dermatology #researchlife #imgjourney – at Chicago, IL
1
92
📣 BTK inhibitors, including #remibrutinib, #fenebrutinib, and #rilzabrutinib, showed promising efficacy in #chronicspontaneousurticaria, with consistent improvements in complete response and well-controlled disease across weeks 4, 8, and 12.
#dermatology
journals.sagepub.com/doi/10.… – at Quito, Ecuador
1
94
Advancing #science extends beyond publishing manuscripts; it also involves active participation in the #peerreview process. I am grateful for every opportunity to learn and give back to the #scientific community
#skin #dermatology #research #academic #metaanalysis @JAMADerm
Excited to share our latest publication!DFD-29 40 mg QD showed better efficacy than #doxycycline 40 mg QD in moderate-to-severe #rosacea, with higher treatment success and greater reduction of inflammatory lesions at week 16, while maintaining a similar safety profile.
1
1
153
Martin Cevallos-Cueva, MD retweeted
Ruxolitinib Cream Shows Strong Benefits in Atopic Dermatitis
A new updated #metaanalysis of five #randomizedtrials (n=1912) confirms that #ruxolitinib cream significantly improves #atopicdermatitis outcomes compared with vehicle.
✨ Key findings:
• Higher rates of #IGA treatment success at 4 and 8 weeks
• Significant improvement in #EASI75 and #itch reduction
• Consistent benefits across ages and doses
• Safety profile comparable to vehicle, with no increased risk of #adverseevents
📌 Takeaway: Ruxolitinib cream is an effective and well‑tolerated #topical option for managing atopic dermatitis.
🔗 doi.org/10.1111/pai.70281
#pai_journal #systematicreview #ruxolitinibcream #AD @MartinCevallosC
📢 : Our recent study highlights #Imiquimod 5% as an effective non-surgical treatment option for #LentigoMaligna of the head, neck, and face.
#Dermatology #MohsSurgery #DermSurgery #Melanoma #SkinCancer #SkinHealth #JEADV #EADV
doi.org/10.1111/jdv.70141
1
168
Our study shows that in patients with #AndrogenicAlopecia, single-spin #PRP #centrifugation method achieves better outcomes than double-spin PRP, increasing #hair density, terminal hair, and platelet count, while reducing vellus hair.
doi.org/10.3389/fmed.2025.16…
1
175
Understanding how the tumor-intrinsic and microenvironmental factors drive cancer resistance is key to developing novel combinations and immunomodulatory strategies to overcome it.
#SkinCancer #Melanoma #Immunotherapy #CheckpointInhibitors
doi.org/10.1002/aac2.70000 – at Quito, Ecuador
1
187
Both #PulsedFieldAblation and vHPSD #RadiofrequencyAblation are effective and safe options for treating #AtrialFibrillation. PFA is associated
with shorter procedure times but required longer fluoroscopy
times.
doi.org/10.36660/abc.2024084… – at Quito, Ecuador
1
151
Our meta-analysis of 7 RCTs highlights the value of #tapinarof and #benvitimod as effective non-steroidal options for #AtopicDermatitis, demonstrating significant improvements in the EASI, IGA and pruritus scores, with no sigficant differences in SAEs.
onlinelibrary.wiley.com/doi/… – at Quito, Ecuador
1
145
Honored to present at #EADV congress.
#BTKinhibitors show promising results for patients with #CSU inadequately controlled with antihistamines, consistently outperforming placebo at weeks 4 and 12 in UAS7=0.
@eadv
#chronicspontaneousurticaria #allergy #dermatology #remibrutinib – at Paris, France
2
599
























